<!DOCTYPE html><html lang="en"><head><script type="text/javascript" src="https://web.archive.org/_static/js/bundle-playback.js?v=HxkREWBo" charset="utf-8"></script>
<script type="text/javascript" src="https://web.archive.org/_static/js/wombat.js?v=txqj7nKC" charset="utf-8"></script>
<script>window.RufflePlayer=window.RufflePlayer||{};window.RufflePlayer.config={"autoplay":"on","unmuteOverlay":"hidden"};</script>
<script type="text/javascript" src="https://web.archive.org/_static/js/ruffle/ruffle.js"></script>
<script type="text/javascript">
    __wm.init("https://web.archive.org/web");
  __wm.wombat("https://openlongevity.com/companies/xvivo-perfusion/","20220704153658","https://web.archive.org/","web","/_static/",
	      "1656949018");
</script>
<link rel="stylesheet" type="text/css" href="https://web.archive.org/_static/css/banner-styles.css?v=S1zqJCYt" />
<link rel="stylesheet" type="text/css" href="https://web.archive.org/_static/css/iconochive.css?v=3PDvdIFv" />
<!-- End Wayback Rewrite JS Include -->
<meta name="viewport" content="width=device-width, user-scalable=no, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0"/><meta property="fb:pages" content="1498050460442929"/><meta property="fb:app_id" content="1105739682944582"/><meta property="og:type" content="website"/><link rel="shortcut icon" sizes="32x32" href="https://web.archive.org/web/20220704153658im_/https://openlongevity.com/static/80lv/favicon.ico" type="image/x-icon"/><link rel="apple-touch-icon" sizes="180x180" href="https://web.archive.org/web/20220704153658im_/https://openlongevity.com/static/images/favicons/80lv/apple-touch-icon.png"/><link rel="icon" type="image/png" sizes="512x512" href="https://web.archive.org/web/20220704153658im_/https://openlongevity.com/static/images/favicons/80lv/android-chrome-512x512.png"/><link rel="icon" type="image/png" sizes="192x192" href="https://web.archive.org/web/20220704153658im_/https://openlongevity.com/static/images/favicons/80lv/android-chrome-192x192.png"/><link rel="icon" type="image/png" sizes="32x32" href="https://web.archive.org/web/20220704153658im_/https://openlongevity.com/static/images/favicons/80lv/favicon-32x32.png"/><link rel="icon" type="image/png" sizes="16x16" href="https://web.archive.org/web/20220704153658im_/https://openlongevity.com/static/images/favicons/80lv/favicon-16x16.png"/><link rel="mask-icon" href="https://web.archive.org/web/20220704153658im_/https://openlongevity.com/static/images/favicons/80lv/safari-pinned-tab.svg" color="white"/><link rel="manifest" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/static/80lv/site.webmanifest"/><meta name="msapplication-config" content="/static/80lv/browserconfig.xml"/><link rel="preload" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/static/fonts/euclid_circular_b_regular-webfont.woff" as="font" type="font/woff" crossorigin=""/><link rel="preload" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/static/fonts/euclid_circular_b_semibold-webfont.woff" as="font" type="font/woff" crossorigin=""/><link rel="preload" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/static/fonts/euclid_circular_b_bold-webfont.woff" as="font" type="font/woff" crossorigin=""/><link rel="preload" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/_next/static/JsdwEs5cXyMapal2m0Rvg/pages/company.js" as="script"/><link rel="preload" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/_next/static/JsdwEs5cXyMapal2m0Rvg/pages/_app.js" as="script"/><link rel="preload" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/_next/static/runtime/webpack-0d76778c7457ff7fae8e.js" as="script"/><link rel="preload" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/_next/static/chunks/commons.452eb587730055019951.js" as="script"/><link rel="preload" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/_next/static/chunks/styles.a1639b96ca7c5e945cb5.js" as="script"/><link rel="preload" href="https://web.archive.org/web/20220704153658/https://openlongevity.com/_next/static/runtime/main-6c6a0af05a87343f5b79.js" as="script"/><link rel="stylesheet" href="https://web.archive.org/web/20220704153658cs_/https://openlongevity.com/_next/static/css/commons.84dc8cb0.chunk.css"/><link rel="stylesheet" href="https://web.archive.org/web/20220704153658cs_/https://openlongevity.com/_next/static/css/styles.7dfdc040.chunk.css"/></head><body><div id="__next"></div><script id="__NEXT_DATA__" type="application/json">{"dataManager":"[]","props":{"isServer":true,"initialState":{"responsive":{"isServer":true,"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isOnlyDesktop":true,"isOnlyTablet":false,"isTablet":false,"isTabletMedium":false,"isVerticalTablet":false,"isVerticalSmallTablet":false,"isPhone":false,"isPhoneXs":false},"modal":{"modalType":null,"modalProps":{}},"home":{"page":1,"isLoadingArticles":false,"meta":{},"content":[],"articles":{},"error":null,"isLoading":false,"isLoaded":false,"isAmp":false,"isLoadingCategory":false,"isLoadedCategory":true,"categories":[{"id":49,"slug":"analiz-biotekha","name":"Анализ биотеха"},{"id":52,"slug":"genetika","name":"Генетика"},{"id":95,"slug":"razbiraemsya-v-terminakh","name":"Разбираемся в терминах"},{"id":62,"slug":"biologiya-stareniya","name":"Биология старения"},{"id":55,"slug":"finansirovanie-bessmertiya","name":"Финансирование бессмертия"},{"id":60,"slug":"diagnostika-i-biomarkery","name":"Диагностика и биомаркеры"},{"id":57,"slug":"vsyo-o-mezhkletochnom-matrikse","name":"Всё о межклеточном матриксе"},{"id":63,"slug":"svyaz-teorii-stareniya-zabolevanii-i-genov","name":"Связь теорий старения, заболеваний и генов"},{"id":88,"slug":"kak-po-raznomu-stareyut-raznye-zhivotnye","name":"Как по-разному стареют разные животные"},{"id":94,"slug":"transgumanizm","name":"Трансгуманизм"},{"id":97,"slug":"ol_projects","name":"Проекты Open Longevity"},{"id":98,"slug":"drugie-interesnye-proekty","name":"Другие интересные проекты"},{"id":99,"slug":"knizhnaya-polka","name":"Книжная полка"}],"tags":[{"id":159,"slug":"epigenetika","name":"Эпигенетика"},{"id":160,"slug":"epigeneticheskaya-onkologiya","name":"Эпигенетическая онкология"},{"id":164,"slug":"open-genes","name":"Open Genes"},{"id":165,"slug":"issledovaniya-na-lyudyakh","name":"Исследования на людях"},{"id":166,"slug":"issledovaniya-na-myshakh","name":"Исследования на мышах"},{"id":167,"slug":"issledovaniya-na-chelovecheskikh-kletkakh","name":"Исследования на человеческих клетках"},{"id":168,"slug":"biotekh-matchast","name":"Биотех: матчасть"},{"id":169,"slug":"biotekh-za-kem-sledit","name":"Биотех: за кем следить"},{"id":170,"slug":"biotekh-kalendar","name":"Биотех: календарь"},{"id":171,"slug":"biotekh-ocenka-sektora","name":"Биотех: оценка сектора"},{"id":172,"slug":"stutus-fda-priority-review","name":"Стутус FDA: Priority review"},{"id":173,"slug":"stutus-fda-fast-track","name":"Стутус FDA: Fast Track"},{"id":174,"slug":"status-fda-breakthrough-therapy-designation","name":"Статус FDA: Breakthrough Therapy Designation"},{"id":175,"slug":"covid-19","name":"COVID-19"},{"id":176,"slug":"status-fda-accelerated-approval","name":"Статус FDA: Accelerated Approval"},{"id":177,"slug":"status-fda-orphan-drug-designation","name":"Статус FDA : Orphan Drug Designation"},{"id":178,"slug":"first-in-class","name":"First-In-Class"},{"id":179,"slug":"best-in-class","name":"Best-in-Class"},{"id":180,"slug":"kompanii-s-sobstvennoi-platformoi","name":"Компании с собственной платформой"},{"id":181,"slug":"gennaya-terapiya","name":"Генная терапия"},{"id":182,"slug":"klinicheskie-issledovaniya","name":"Клинические исследования"},{"id":183,"slug":"terapiya-stvolovymi-kletkami","name":"Терапия стволовыми клетками"},{"id":184,"slug":"transplantologiya","name":"Трансплантология"},{"id":185,"slug":"crispr","name":"CRISPR"}],"featured":{}},"about":{"about":{"title":"О нас","content":"Open Longevity — это сообщество рациональных людей, действующих в пользу радикального продления жизни. Наш основной фокус — борьба со старением.\u003cbr\u003e\u003cbr\u003eМы собираем и структурируем существующие данные, пишем научные и научно-популярные обзоры и книги, и, конечно же, запускаем исследования в области биологии старения и смежных областях.\u003cbr\u003e\u003cbr\u003eСтарение — сложнейшая научная проблема, требующая комплексного междисциплинарного подхода. И здесь важно не забывать о вопросах финансирования науки, о формировании социального заказа, о роли политики, общества и каждого человека в частности. Поэтому у нас очень разные проекты: от клинических исследований по инициативе пациентов до введения новых лабораторных моделей, от аналитики биотеха до арт инициатив, от проведения школ долголетия до разработки новых улучшенных баз данных."},"contacts":{"title":"Кто мы","text":"Нас много: более 40 членов команды и десятки волонтёров. И да, у нас два CEO. С ребятами из Open Longevity вы можете познакомиться по ссылке ниже.","buttonHref":"https://web.archive.org/web/20220704153658/https://openlongevity.org/team","buttonText":"Вся команда OL","items":[]},"media":{"title":"Поддержать проект","content":"Наша работа возможна благодаря поддержке спонсоров и волонтёров. О том, как можно поддержать некоммерческую организацию Open Longevity, вы можете узнать по ссылке ниже.","url":"https://web.archive.org/web/20220704153658/https://openlongevity.org/donate","buttonTitle":"Как поддержать","files":[{"id":10}]},"mediaKit":{"title":"Ещё один сайт Open Longevity","content":"Вы находитесь на новом сайте OL. И постепенно мы объединим его со старым. Но пока этого не произошло, вы можете найти наши архивные материалы и описания текущих проектов по ссылки ниже.","buttonTitle":"Перейти на сайт","url":"https://web.archive.org/web/20220704153658/https://openlongevity.org/","files":[{"id":10}]},"meta":{"meta-title":{"type":"name","name":"title","content":"О нас"},"schema-name":{"type":"itemprop","name":"name","content":"openlongevity"},"og-og:title":{"type":"property","name":"og:title","content":"О нас"},"og-og:type":{"type":"property","name":"og:type","content":"article"},"article-article:published_time":{"type":"property","name":"article:published_time","content":"2019-07-11T11:57:45+00:00"},"article-article:modified_time":{"type":"property","name":"article:modified_time","content":"2021-09-14T11:57:45+00:00"},"twitter-twitter:card":{"type":"name","name":"twitter:card","content":"summary_large_image"},"twitter-twitter:title":{"type":"name","name":"twitter:title","content":"openlongevity"},"fb-fb:pages":{"type":"property","name":"fb:pages","content":"199792914149372"}},"promo":{"header":[],"content":[],"footer":[]}},"articles":{"isLoading":false,"isLoaded":false,"data":{},"pages":{},"postComments":false,"isLoadingPreview":false,"isLoadedPreview":false,"isFailrulePreview":false,"preview":{},"isPreview":false,"error":null,"errors":{"article":null,"preview":null,"interesting":null,"comments":{"form":null,"items":null}}},"category":{"page":1,"sort":"new","isLoadingArticles":false,"sortOptions":[{"value":"new","label":"Новые"},{"value":"popular","label":"Популярные"},{"value":"discussed","label":"Активно обсуждаются"}],"categories":{},"errors":{}},"company":{"isLoading":false,"isLoaded":false,"formData":{"website":"","title":""},"error":{}},"events":{"events":{},"meta":[],"promo":{},"isLoading":false},"companies":{"data":{},"isLoading":false,"isLoaded":false,"pages":{"xvivo-perfusion":{"isLoading":false,"isLoaded":true,"id":88,"slug":"xvivo-perfusion","title":"XVIVO Perfusion","stock_market":"STO","ticker":"XVIVO.ST","description":"Разрабатывает решения для сохранения и перфузии органов, тканей и клеток перед трансплантацией","is_public":1,"location":"Gothenburg, Sweden","market_cap":6267144192,"employees_count":118,"rnd_spending":null,"prr":0,"cash_and_equivalents":null,"operating_expenses":null,"revenue":1000000,"cash_burn":0,"has_grants":0,"has_fda_special_status":0,"has_drug":0,"has_panic_attack":0,"cr_codes":"NCT01615484","cr_phases":"","is_age_related":0,"image":{"original":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/88/60f10a088a812.png","src":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/88/images/60f10a088a812/contain_144x144.png","src2x":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/88/images/60f10a088a812/contain_288x288.png"},"tags":[{"name":"Трансплантология","slug":"transplantologiya","type":"tag"}],"genes":[],"therapies":[],"research_phases":[],"molecule_sizes":[{"id":4,"name":"Неприменимо"}],"agings":[],"diseases":[],"vendors":[],"official":{"site":"www.xvivoperfusion.com","url":"https://web.archive.org/web/20220704153658/https://www.xvivoperfusion.com","social":[]},"content":[{"id":292,"type":"editor","content":{"text":"\u003cp\u003e\u003cspan data-sheets-value=\"{\u0026quot;1\u0026quot;:2,\u0026quot;2\u0026quot;:\u0026quot;Dag Andersson \u0026mdash; CEO, был генеральнным директором Diaverum AB в 2008-2018 годах, а до этого занимал руководящие должности в M\u0026ouml;lnlycke Health Care AB в 1993-2007 годах.                                                  Christoffer Rosenblad\u0026mdash; COO \u0026amp; deputy CEO, до этого занимал финансовые должности в Ciba Vision Nordic AB и LG Electronics.\u0026quot;}\" data-sheets-userformat=\"{\u0026quot;2\u0026quot;:13249,\u0026quot;3\u0026quot;:{\u0026quot;1\u0026quot;:0},\u0026quot;9\u0026quot;:0,\u0026quot;10\u0026quot;:1,\u0026quot;11\u0026quot;:4,\u0026quot;12\u0026quot;:0,\u0026quot;15\u0026quot;:\u0026quot;Arial\u0026quot;,\u0026quot;16\u0026quot;:10}\" data-sheets-textstyleruns=\"[null,0,{\u0026quot;5\u0026quot;:1}]{\u0026quot;1\u0026quot;:13}[null,216,{\u0026quot;5\u0026quot;:1}]{\u0026quot;1\u0026quot;:237}\"\u003e\u003cstrong\u003eDag Andersson\u003c/strong\u003e \u0026mdash; CEO, был генеральнным директором Diaverum AB в 2008-2018 годах, а до этого занимал руководящие должности в M\u0026ouml;lnlycke Health Care AB в 1993-2007 годах. \u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u0026nbsp;\u003c/p\u003e\u003cp\u003e\u003cspan data-sheets-value=\"{\u0026quot;1\u0026quot;:2,\u0026quot;2\u0026quot;:\u0026quot;Dag Andersson \u0026mdash; CEO, был генеральнным директором Diaverum AB в 2008-2018 годах, а до этого занимал руководящие должности в M\u0026ouml;lnlycke Health Care AB в 1993-2007 годах.                                                  Christoffer Rosenblad\u0026mdash; COO \u0026amp; deputy CEO, до этого занимал финансовые должности в Ciba Vision Nordic AB и LG Electronics.\u0026quot;}\" data-sheets-userformat=\"{\u0026quot;2\u0026quot;:13249,\u0026quot;3\u0026quot;:{\u0026quot;1\u0026quot;:0},\u0026quot;9\u0026quot;:0,\u0026quot;10\u0026quot;:1,\u0026quot;11\u0026quot;:4,\u0026quot;12\u0026quot;:0,\u0026quot;15\u0026quot;:\u0026quot;Arial\u0026quot;,\u0026quot;16\u0026quot;:10}\" data-sheets-textstyleruns=\"[null,0,{\u0026quot;5\u0026quot;:1}]{\u0026quot;1\u0026quot;:13}[null,216,{\u0026quot;5\u0026quot;:1}]{\u0026quot;1\u0026quot;:237}\"\u003e\u003cstrong\u003eChristoffer Rosenblad\u003c/strong\u003e \u0026mdash; COO \u0026amp; deputy CEO, до этого занимал финансовые должности в Ciba Vision Nordic AB и LG Electronics.\u003c/span\u003e\u003c/p\u003e","isQuote":false}}],"articles":{"total":1,"items":{"1":{"id":72,"slug":"pyat-kompanii-rabotayushikh-v-oblasti-transplantologii","title":"Пять компаний, работающих в области трансплантологии","description":"Всё, что мы так любим: ксенотрансплантация, внеклеточный матрикс, перфузионные инкубаторы и прочие сущности, которые так дороги настоящим трансгуманистам.","image":{"original":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/post/72/617278fb3a09a.jpeg","src":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/post/72/images/617278fb3a09a/contain_400x360.jpeg","src2x":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/post/72/images/617278fb3a09a/contain_800x720.jpeg","blur":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/post/72/images/617278fb3a09a/blur_b35d52c9_0x0.jpeg"},"preview":{"original":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/post/72/618502660b65c.jpeg","src":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/post/72/images/618502660b65c/contain_516x268.jpeg","src2x":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/post/72/images/618502660b65c/contain_1032x536.jpeg"},"tags":[{"name":"Анализ биотеха","slug":"analiz-biotekha"}]}}},"meta":{"meta-title":{"type":"name","name":"title","content":"XVIVO Perfusion"},"meta-description":{"type":"name","name":"description","content":"Разрабатывает решения для сохранения и перфузии органов, тканей и клеток перед трансплантацией"},"schema-name":{"type":"itemprop","name":"name","content":"XVIVO Perfusion"},"schema-description":{"type":"itemprop","name":"description","content":"Разрабатывает решения для сохранения и перфузии органов, тканей и клеток перед трансплантацией"},"schema-image":{"type":"itemprop","name":"image","content":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/meta/147/images/616f10329486b/contain_1200x630.png"},"og-og:title":{"type":"property","name":"og:title","content":"XVIVO Perfusion"},"og-og:description":{"type":"property","name":"og:description","content":"Разрабатывает решения для сохранения и перфузии органов, тканей и клеток перед трансплантацией"},"og-og:image":{"type":"property","name":"og:image","content":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/meta/147/images/616f10329486b/contain_1200x630.png"},"og-og:type":{"type":"property","name":"og:type","content":"article"},"og-og:image:type":{"type":"property","name":"og:image:type","content":"image/png"},"og-og:image:width":{"type":"property","name":"og:image:width","content":1200},"og-og:image:height":{"type":"property","name":"og:image:height","content":630},"article-article:published_time":{"type":"property","name":"article:published_time","content":"2021-07-16T04:24:40+00:00"},"article-article:modified_time":{"type":"property","name":"article:modified_time","content":"2022-07-04T15:20:19+00:00"},"twitter-twitter:card":{"type":"name","name":"twitter:card","content":"summary_large_image"},"twitter-twitter:image:src":{"type":"name","name":"twitter:image:src","content":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/meta/147/images/616f10329486b/contain_440x220.png"},"twitter-twitter:title":{"type":"name","name":"twitter:title","content":"XVIVO Perfusion"},"twitter-twitter:description":{"type":"name","name":"twitter:description","content":"Разрабатывает решения для сохранения и перфузии органов, тканей и клеток перед трансплантацией"}},"promo":{"header":[],"vendor":[],"sidebar":[],"footer":[]},"partners":{"title":"Пять компаний, на которые стоит обратить внимание в этом месяце","action":"Посмотреть подборку","url":"https://web.archive.org/web/20220704153658/https://openlongevity.com/articles/podborka-kompanii-s-pdufa-v-noyabre-dekabre/","items":[{"id":1325,"title":"CTI BioPharma","slug":"cti-biopharma","description":"\u003cp\u003eСпециализируется на приобретении, разработке и коммерциализации новых таргетных методов лечения рака крови в Соединенных Штатах.\u003c/p\u003e","image":{"original":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1325/615301637dfce.png","src":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1325/images/615301637dfce/contain_144x144.png","src2x":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1325/images/615301637dfce/contain_288x288.png"}},{"id":1324,"title":"BeyondSpring","slug":"beyondspring","description":"\u003cp\u003e\u003cspan class=\"VIiyi\" lang=\"ru\"\u003e\u003cspan class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"ru\" data-language-to-translate-into=\"en\" data-phrase-index=\"0\"\u003eРазработка и коммерциализация иммуноонкологических методов лечения рака.\u003c/span\u003e\u003c/span\u003e В данный момент ожидают решения по препарату Plinabulin.\u003c/p\u003e","image":{"original":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1324/6152049826b9f.png","src":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1324/images/6152049826b9f/contain_144x144.png","src2x":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1324/images/6152049826b9f/contain_288x288.png"}},{"id":1323,"title":"Legend Biotech","slug":"legend-biotech","description":"\u003cp style=\"background-color: transparent;\"\u003eКомпания, занимающаяся разработкой клеточных терапий. В данный момент ожидает решения препарат Ciltacabtagene autoleucel.\u003c/p\u003e","image":{"original":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1323/6152019859998.png","src":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1323/images/6152019859998/contain_144x144.png","src2x":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1323/images/6152019859998/contain_288x288.png"}},{"id":1322,"title":"Fennec Pharmaceuticals","slug":"fennec-pharmaceuticals","description":"\u003cp\u003eРазрабатывает препарат для лечения потери слуха, вызванной цисплатином.\u003c/p\u003e","image":{"original":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1322/6151fd1416018.png","src":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1322/images/6151fd1416018/contain_144x144.png","src2x":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/1322/images/6151fd1416018/contain_288x288.png"}},{"id":37,"title":"Agenus","slug":"agenus","description":"\u003cp\u003eСпециализируется на имммуноокологии: иммунная система используется для контроля или лечения рака.\u003c/p\u003e","image":{"original":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/37/614adde40555e.png","src":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/37/images/614adde40555e/contain_144x144.png","src2x":"https://web.archive.org/web/20220704153658/https://openlongevity.com/upload/vendor/37/images/614adde40555e/contain_288x288.png"}}]}}},"isLoadingArticles":false,"error":{}},"genes":{"data":{},"isLoading":false,"isLoaded":false,"pages":{},"isLoadingArticles":false,"error":{}},"diseases":{"data":{},"isLoading":false,"isLoaded":false,"pages":{},"isLoadingArticles":false,"error":{}},"mechanisms":{"data":{},"isLoading":false,"isLoaded":false,"pages":{},"isLoadingArticles":false,"error":{}},"author":{"page":1,"sort":"new","isLoadingArticles":false,"sortOptions":[{"value":"new","label":"Новые"},{"value":"popular","label":"Популярные"},{"value":"discussed","label":"Активно обсуждаются"}],"pages":{},"errors":{}},"auth":{"isAuthenticated":false,"isLoaded":false,"roles":[],"token":""},"gdpr":{"isAcceptGdpr":false},"subscribe":{"isLoading":false,"isLoaded":false,"success":false,"error":""},"promo":{"isBot":true,"isLoaded":false,"isLoading":false,"isInitPay2Pay":false,"types":["big-image","branding","custom","image","pre-sale","tooltip"],"promos":[],"required":{},"request":{},"error":null},"likeArticles":{"isLoading":false,"total":0,"articles":[],"error":null},"futureEvents":{"isLoading":false,"total":0,"items":[],"error":null},"mediaKit":{"isLoading":false,"error":null},"profile":{"isLoading":false,"isLoaded":false,"formData":{"city":"","state":"","country":"","name":"","surname":"","position":"","workStatus":false,"workTypesSelected":[],"image":null,"email":"","rfp_show_status":true},"id":null,"workTypes":[],"avatar":"","error":{}}},"initialProps":{"pageProps":{"slug":"xvivo-perfusion"},"status":200}},"page":"/company","query":{"slug":"xvivo-perfusion"},"buildId":"JsdwEs5cXyMapal2m0Rvg","dynamicBuildId":false,"runtimeConfig":{"LOGIN_PROJECT":"42fd4730-1616-11ec-bc85-42010aa80004","XA_SERVER":"https://web.archive.org/web/20220704153658/https://datagather-test.xsolla.com/hit","COUNTER_ID":"1024"}}</script><script async="" id="__NEXT_PAGE__/company" src="https://web.archive.org/web/20220704153658js_/https://openlongevity.com/_next/static/JsdwEs5cXyMapal2m0Rvg/pages/company.js"></script><script async="" id="__NEXT_PAGE__/_app" src="https://web.archive.org/web/20220704153658js_/https://openlongevity.com/_next/static/JsdwEs5cXyMapal2m0Rvg/pages/_app.js"></script><script src="https://web.archive.org/web/20220704153658js_/https://openlongevity.com/_next/static/runtime/webpack-0d76778c7457ff7fae8e.js" async=""></script><script src="https://web.archive.org/web/20220704153658js_/https://openlongevity.com/_next/static/chunks/commons.452eb587730055019951.js" async=""></script><script src="https://web.archive.org/web/20220704153658js_/https://openlongevity.com/_next/static/chunks/styles.a1639b96ca7c5e945cb5.js" async=""></script><script src="https://web.archive.org/web/20220704153658js_/https://openlongevity.com/_next/static/runtime/main-6c6a0af05a87343f5b79.js" async=""></script><div id="tooltip-asset"></div><span id="closeButton"></span></body></html><!--
     FILE ARCHIVED ON 15:36:58 Jul 04, 2022 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 04:33:54 Dec 21, 2024.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  captures_list: 0.643
  exclusion.robots: 0.032
  exclusion.robots.policy: 0.01
  esindex: 0.01
  cdx.remote: 5.015
  LoadShardBlock: 138.31 (3)
  PetaboxLoader3.datanode: 183.183 (4)
  load_resource: 176.011
  PetaboxLoader3.resolve: 104.75
-->